Jim Zarroli

Jim Zarroli is a business reporter for NPR News, based at NPR's New York bureau.

He covers economics and business news including fiscal policy, the Federal Reserve, the job market and taxes

Over the years, he's reported on recessions and booms, crashes and rallies, and a long string of tax dodgers, insider traders and Ponzi schemers. He's been heavily involved in the coverage of the European debt crisis and the bank bailouts in the United States.

Prior to moving into his current role, Zarroli served as a New York-based general assignment reporter for NPR News. While in this position he covered the United Nations during the first Gulf War. Zarroli added to NPR's coverage of the aftermath of Hurricane Katrina, the London transit bombings and the September 11, 2001 attacks on the World Trade Center.

Before joining the NPR in 1996, Zarroli worked for the Pittsburgh Press and wrote for various print publications.

Zarroli graduated from Pennsylvania State University.

China unveiled its first passenger jet Monday, part of an effort to compete in the lucrative commercial aircraft business now dominated by Boeing and Airbus.

The single-aisle, twin-engine C919 was developed by the state-run Commercial Aircraft Corporation of China, or Comac. The jet was shown to a large crowd of government dignitaries in a hangar at an assembly plant outside Shanghai, near Pudong International Airport.

Valeant Pharmaceuticals International is ending its relationship with Philidor Rx Services, because of questions raised about whether it was using the specialty pharmacy to boost sales of Valeant drugs over cheaper versions.

As a result, Philidor will shut down as soon as possible, The Wall Street Journal reported.

The U.S. economy grew at a considerably slower pace during the third quarter as companies cut back on the size of their inventories, the Commerce Department said.

Growth came in at an annual rate of 1.5 percent — a sharp slowdown from the 3.9 percent gain recorded in the preceding quarter. The economy has grown at about 2 percent so far this year.

Two of the nation's largest drug store chains want to merge, a deal that's certain to face intense scrutiny from federal regulators worried about its potential harm to consumers.

Walgreens Boots Alliance, the company that owns Walgreens drugstores, said yesterday that it has agreed to buy Rite Aid for about $9 a share, in a deal worth about $17 billion.

Lions are rapidly disappearing in large parts of Africa, and their population could be reduced by half outside of protected areas over the next two decades, according to a study published Tuesday in the Proceedings of the National Academy of Sciences.